Article Text

Download PDFPDF
Authors’ reply
  1. D Aletaha,
  2. J Smolen
  1. Department of Rheumatology, University of Vienna, Austria

    Statistics from Altmetric.com

    Authors’ reply

    The Finnish data presented by Drs Klaukka and Kaarela, which confirm the trend that we saw in our patient populations1 as well as in the survey of rheumatologists,2 are highly appreciated. They clearly show how drastically the use of disease modifying antirheumatic drugs (DMARDs) has changed over the past decade. Importantly, not only has …

    View Full Text